PlainRecalls
FDA Drug Moderate Class II Terminated

Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56), b) 90-count bottle (NDC 0093-7617-98), Rx only, Manufactured In Israel By: Teva Pharmaceutical, IND. LTD., Jerusalem, 9777402, Israel, Manufactured For: Teva Pharmaceutical USA, INC., North Wales, PA 19454

Reported: January 23, 2019 Initiated: December 19, 2018 #D-0381-2019

Product Description

Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56), b) 90-count bottle (NDC 0093-7617-98), Rx only, Manufactured In Israel By: Teva Pharmaceutical, IND. LTD., Jerusalem, 9777402, Israel, Manufactured For: Teva Pharmaceutical USA, INC., North Wales, PA 19454

Reason for Recall

Failed dissolution specifications

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
181,456 bottles
Distribution
U.S.A. nationwide
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56), b) 90-count bottle (NDC 0093-7617-98), Rx only, Manufactured In Israel By: Teva Pharmaceutical, IND. LTD., Jerusalem, 9777402, Israel, Manufactured For: Teva Pharmaceutical USA, INC., North Wales, PA 19454. Recalled by Teva Pharmaceuticals USA. Units affected: 181,456 bottles.
Why was this product recalled?
Failed dissolution specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on January 23, 2019. Severity: Moderate. Recall number: D-0381-2019.